Literature DB >> 17430761

Recognition and management of severe cutaneous drug reactions.

Sandra R Knowles1, Neil H Shear.   

Abstract

Cutaneous drug reactions are among the most common types of adverse drug reactions. This article focuses on the recognition and management of severe cutaneous drug eruptions, including the drug-hypersensitivity syndrome, serum sickness-like reaction, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Cutaneous reactions are considered severe when they can result in serious skin damage or involve multiple organs. Some of these reactions can cause significant morbidity or death. Each may be confounded by diagnostic difficulties, confusion in ascertaining causality, and treatment challenges.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430761     DOI: 10.1016/j.det.2007.01.011

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

1.  Staphylococcal scalded skin syndrome in a preterm newborn presenting within first 24 h of life.

Authors:  Prem Arora; Vaneet Kumar Kalra; Sharayu Rane; Eric J McGrath; Ricardo Zegarra-Linares; Sanjay Chawla
Journal:  BMJ Case Rep       Date:  2011-12-21

Review 2.  Severe cutaneous adverse drug reactions.

Authors:  Rajesh Verma; Biju Vasudevan; Vijendran Pragasam
Journal:  Med J Armed Forces India       Date:  2013-03-17

3.  DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related?

Authors:  Zahrae Sandouk; Zaid Alirhayim; Dania Khoulani; Syed Hassan
Journal:  BMJ Case Rep       Date:  2012-11-14

4.  Does sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome?

Authors:  Virgínia Barbeitos Cruz; Luiz Fernando Fróes Fleury Júnior; Christiane Reis Kobal; Nilzio Antonio da Silva
Journal:  Braz J Infect Dis       Date:  2022-02-28       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.